Perrigo (PRGO) reported $4.3B in revenue for fiscal 2025, −2.8% year on year. That ranks #896 by revenue among 2853 SEC filers and #79 in Healthcare. It posted a net loss of −$1.4B for the same year. Revenue has grown 93.5% a year on average since 2012 ($800,000 then). The fiscal 2025 balance sheet shows $8.5B in total assets, $532M in cash and $3.6B in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $4.3B | −2.8% | FY20252025-12-31 |
| Gross profitGrossProfit | $1.5B | −3.1% | FY20252025-12-31 |
| Operating incomeOperatingIncomeLoss | −$1.1B | −$1.2B | FY20252025-12-31 |
| Net incomeNetIncomeLoss | −$1.4B | −$1.3B | FY20252025-12-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $239M | −34.3% | FY20252025-12-31 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $93.4M | −21.0% | FY20252025-12-31 |
| Total assetsAssets | $8.5B | −11.5% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $2.9B | −32.0% | FY20252025-12-31 |
| CashCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | $532M | −4.9% | FY20252025-12-31 |
| Long-term debtLongTermDebtNoncurrent | $3.6B | +0.6% | FY20252025-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-28 | $969M | −$399M | Open → |
| Q2 20262026-06-27 | $1.0B | $74.5M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Where this sits in its sector
Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.
| Where this sits in its sector | FY2025 | Position in sector |
|---|---|---|
| Net marginRank 155 of 161 companies compared | −33.5% | |
| Operating marginRank 152 of 160 companies compared | −26.4% | |
| R&D as share of revenueRank 90 of 102 companies compared | 2.2% | |
| Cash as share of revenueRank 75 of 160 companies compared | 12.5% |
All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.
Profile
- Legal name
- Perrigo Co Plc
- Ticker
- PRGO
- Exchange
- NYSE
- SIC classification
- Pharmaceutical Preparations (2834)
- Fiscal year end
- 12-31
- CIK
- 0001585364
Filings
- 10-QAug 5, 2026Open filing →
- 10-QMay 6, 2026Open filing →
- 10-KFeb 26, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| Cno FinancialCNO | $4.5B | $229M |
| Idexx LaboratoriesIDXX | $4.3B | $1.1B |
| Jazz PharmaceuticalsJAZZ | $4.3B | −$356M |
| PerrigoPRGO | $4.3B | −$1.4B |
| Cooper CompaniesCOO | $4.1B | $375M |
| Align TechnologyALGN | $4.0B | $410M |
| Charles River Laboratories InternationalCRL | $4.0B | −$144M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Perrigo — Key figures |url=https://companiesranked.com/en/company/perrigo |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Perrigo — Key figures. CompaniesRanked. https://companiesranked.com/en/company/perrigoBibTeX
@misc{companiesranked-en-company-perrigo-2026,
author = {{CompaniesRanked}},
title = {{Perrigo — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/perrigo}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001585364-26-000009 · February 26, 2026
{{cite web |title=Perrigo — Key figures — 10-K (0001585364-26-000009) |url=https://www.sec.gov/Archives/edgar/data/1585364/000158536426000009/prgo-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-26}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.